External Source

Combining Sabr And Immunotherapies For Nsclc

2022 1:00
Synopsis
Stephanie Kroeze, MD, PhD , University Hospital of Zürich (Universitätsspital Zürich), Zurich, Switzerland, talks on the combination ...

You Might Also Like

Toxicities associated with combining stereotactic ablative radiotherapy (SABR) and immunotherapy 1:36
Toxicities Associated With Combining Stereotactic Ablative R...
2022
Combining and Sequencing Immunotherapies in NSCLC 4:51
Combining And Sequencing Immunotherapies In Nsclc
2016
A Phase II study of I-SABR in early or recurrent NSCLC 1:49
A Phase Ii Study Of I-sabr In Early Or Recurrent Nsclc
2023
Dr. Hak Choy on Radiation and Immunotherapy in Combination in Lung Cancer 0:32
Dr. Hak Choy On Radiation And Immunotherapy In Combination I...
2016
Dr. Skoulidis on Combining Chemotherapy and Immunotherapy in NSCLC 1:38
Dr. Skoulidis On Combining Chemotherapy And Immunotherapy In...
2017
Chemotherapy and Immunotherapy Combinations are The Future of NSCLC Treatment 1:00
Chemotherapy And Immunotherapy Combinations Are The Future O...
2019
Dr. Patel on Combination Chemotherapy and Immunotherapy in Lung Cancer 1:58
Dr. Patel On Combination Chemotherapy And Immunotherapy In L...
2017
Dr. Bunn on Combining Immunotherapy and Chemotherapy in Lung Cancer 1:31
Dr. Bunn On Combining Immunotherapy And Chemotherapy In Lung...
2017
Combining Radiation and Immune Checkpoint Inhibitors in NSCLC 24:44
Combining Radiation And Immune Checkpoint Inhibitors In Nscl...
2019
Assessing I-SABR in early or recurrent non-small cell lung cancer 0:51
Assessing I-sabr In Early Or Recurrent Non-small Cell Lung C...
2023
Combined Immunotherapy and Chemotherapy for NSCLC 5:27
Combined Immunotherapy And Chemotherapy For Nsclc
2017
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.